Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announces that the equity research company Edison Investment Research has published an updated research note of the company and an executive interview with CEO …
